Mast cell mediators and diagnostic testing in anaphylaxis (tryptase, histamine)
Core concept
Mediators - the timing explains the clinical course
| Class | Mediator | Effect | Kinetics |
|---|---|---|---|
| Preformed (granule) | Histamine | H1: itch, flush, bronchospasm, inc permeability; H2: gastric acid, vasodilatation | Peaks <5-10 min, gone by 30-60 min |
| Tryptase | Protease; the clinical marker | Peaks 60-90 min, detectable ~5 h | |
| Chymase, heparin, TNF, carboxypeptidase | Local | Immediate | |
| Newly synthesised (lipid) | Leukotrienes C4, D4, E4 (the old slow-reacting substance of anaphylaxis) | Sustained bronchoconstriction, mucus, permeability | 5-30 min |
| PGD2 | Flushing, bronchospasm, vasodilatation | 5-30 min | |
| PAF | Hypotension, capillary leak; correlates with severity | Minutes | |
| Cytokines | IL-4, IL-5, IL-13, TNF, chemokines | Late-phase eosinophil and lymphocyte recruitment | 4-12 h |
- Early phase = preformed and lipid mediators = STEROID-RESISTANT -> steroids do not treat the acute reaction; adrenaline does
- Late phase = cellular infiltration = steroid-responsive -> the rationale for steroids in preventing protracted or biphasic reactions (evidence is weak; do not delay adrenaline for them)
- Biphasic reactions in ~5% (up to 20% in some series), typically 4-12 h later
3 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access